Mark Baxter

20PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpidemiological modellingAboriginal and Torres Strait Islander engineeringPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 12, 2026
Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United Kingdom.

Joseph Salf, Aimee Cunningham, Dinakshi Shah

|Jul 04, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.

Lindsay C Spender, Dale M Watt, Mark A Baxter

|Jul 02, 2025
KERMIT: Performance indicators in electronic patient reported outcome measures: a modified Delphi.

Nathaniel Luke Hatton, Mark Baxter, Sally Lewis

|Feb 26, 2025
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)-A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial.

Yuewei Tao, Chim C Lang, Russell D Petty

|Jan 31, 2025
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study.

Mark A Baxter, Michael Rowe, Kieran Zucker

|Dec 26, 2024
TOURISM study (Treatment Outcomes in UteRIne SarcoMa): a 10-year retrospective evaluation of practice in the UK.

Karen E Mactier, Mark A Baxter, Adam L Peters

Pageof 4

Frequent Collaborators

4 joint publications

Russell D Petty

3 joint publications

Michael Rowe

3 joint publications

Peter S Hall

2 joint publications

Cong Zhou